U. Seligsohn

发表

Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes.

U Seligsohn, A. Zivelin, N. Rosenberg, 1997, Clinical chemistry.

A unique interaction between alphaIIb and beta3 in the head region is essential for outside-in signaling-related functions of alphaIIbbeta3 integrin.

M. Landau, N. Rosenberg, U. Seligsohn, 2010, Blood.

Discerning the Ancestry of European Americans in Genetic Association Studies

David Reich, Vincenzo L Pascali, Leif Groop, 2007, PLoS genetics.

A 13‐bp deletion in αIIb gene is a founder mutation that predominates in Palestinian‐Arab patients with Glanzmann thrombasthenia

M. Landau, B. Coller, G. Kenet, 2005, Journal of thrombosis and haemostasis : JTH.

The Human Platelet IIb Gene Is Not Closely Linked to Its Integrin Partner β3

M. Poncz, M. A. Thornton, M. Korostishevsky, 1999 .

The Association of Factor V Leiden and Prothrombin Gene Mutation and Placenta-Mediated Pregnancy Complications: A Systematic Review and Meta-analysis of Prospective Cohort Studies

M. Rodger, I. Greer, U. Seligsohn, 2010, PLoS medicine.

Prerequisites for recombinant factor VIIa‐induced thrombin generation in plasmas deficient in factors VIII, IX or XI

U. Martinowitz, A. Zivelin, U. Seligsohn, 2006, Journal of thrombosis and haemostasis : JTH.

Monitoring oral anticoagulant therapy by telephone communication

S. Berliner, E. Shabtai, U. Seligsohn, 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Mendelian diseases among Roman Jews: implications for the origins of disease alleles.

H. Ostrer, K. Nafa, L. Luzzatto, 1999, The Journal of clinical endocrinology and metabolism.

from Arab patients with Glanzmann thrombasthenia in Israel Platelet vitronectin receptor expression differentiates Iraqi-Jewish

B. Coller, E. Asch, U. Seligsohn, 2011 .

Upregulation of osteoclast α2β1 integrin compensates for lack of αvβ3 vitronectin receptor in Iraqi‐Jewish‐type Glanzmann thrombasthenia

M. Horton, A. Flanagan, N. Rosenberg, 2003, British journal of haematology.

Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel

B. Coller, D. Cheresh, E. Asch, 1991 .

Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency

A. Wolberg, U. Seligsohn, O. Salomon, 2014, Journal of thrombosis and haemostasis : JTH.

Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor.

H. Hemker, S. Béguin, R. Kumar, 1999, Blood.

The Role of Factor XI in Thrombin Generation Induced by Low Concentrations of Tissue Factor

H. Hemker, S. Béguin, A. Zivelin, 2001, Thrombosis and Haemostasis.

Abciximab in Carotid Stenting for Postsurgical Carotid Restenosis: Intermediate Results

U. Rimon, D. Varon, U. Seligsohn, 2000, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

Carrier frequency of the IVS4 + 4 A-->T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population.

A. Auerbach, U. Seligsohn, P. Verlander, 1995, Blood.

Nonarteritic anterior ischemic optic neuropathy is associated with a specific platelet polymorphism located on the glycoprotein Ibalpha gene.

D. Steinberg, R. Dardik, J. Moisseiev, 2004, Ophthalmology.

Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies

U. Seligsohn, O. Salomon, Z. Horowitz, 2009, Thrombosis and Haemostasis.

Inherited Thrombophilia*: Part 2

P. Mannucci, F. Rosendaal, J. Miletich, 1996, Thrombosis and Haemostasis.

Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn.

S. Rapaport, A. Zivelin, U. Seligsohn, 1984, The New England journal of medicine.

The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel.

B. Coller, P. Newman, U. Seligsohn, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients

G. Kenet, N. Rosenberg, U. Seligsohn, 2018, Thrombosis and Haemostasis.

Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor

H. Hemker, S. Béguin, B. Coller, 1999 .

Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel.

B. Coller, D. Cheresh, E. Asch, 1991, Blood.

Variable effects of alpha v suppression on VEGFR-2 expression in endothelial cells of different vascular beds

R. Dardik, U. Seligsohn, T. Livnat, 2009, Thrombosis and Haemostasis.

False‐positive tests for heparin‐induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus

A. Greinacher, R. Pauzner, B. Shenkman, 2009, Journal of thrombosis and haemostasis : JTH.

Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein αIIbβ3 (GPIIb/IIIa) and αvβ3 Receptors Are Not Protected From Atherosclerosis

D. Harats, B. Coller, O. Shpilberg, 2002 .

The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation.

I. Shapira, S. Berliner, V. Shalev, 2007, Thrombosis research.

Purpura Fulminans Induced by Disseminated Intravascular Coagulation following Infection in 2 Unrelated Children with Double Heterozygosity for Factor V Leiden and Protein S Deficiency

G. Kenet, M. Aiach, A. Inbal, 1997, Thrombosis and Haemostasis.

Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction.

H. Hod, E. Kaplinsky, A. Battler, 1990, British heart journal.

Could the 185 deIAG BRCA1 Mutation Be an Ancient Jewish Mutation?

B. Modan, E. Friedman, G. Rechavi, 1997, European journal of human genetics : EJHG.

Thromboembolic events in patients with severe inherited fibrinogen deficiency

U. Seligsohn, A. Rottenstreich, Y. Kalish, 2016, Journal of Thrombosis and Thrombolysis.

Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency.

D. Steinberg, Christine A. Lee, R. T. Sjin, 2003, Blood.

Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews.

D. Goldstein, D. Reich, N. Bradman, 1999, American journal of human genetics.

Genotype-phenotype correlation in combined deficiency of factor V and factor VIII.

P. Platzer, R. Kaufman, D. Ginsburg, 2008, Blood.

Plat el et Vitro nec t in Receptor Exp res s ion Differentiates Iraqi - Jewi s h From Arab Patients With Glanzmann Thrombasthenia in Israel

B. Coller, D. Cheresh, E. Asch, 2003 .

Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking.

B. Coller, S. M. West, U. Seligsohn, 1991, Blood.

Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein (cid:1) IIb (cid:2) 3 (GPIIb/IIIa) and (cid:1) v (cid:2) 3 Receptors Are Not Protected From Atherosclerosis

D. Harats, O. Shpilberg, K. Schiller, 2002 .

Parotid gland hemorrhage as a complication of coumarin compound ingestion

U. Seligsohn, M. Himelfarb, E. Shanon, 2004, Archives of oto-rhino-laryngology.

A relatively high frequency of severe (type III) von Willebrand's disease in Israel

S. Berliner, A. Zivelin, U. Seligsohn, 1986, British journal of haematology.

The inheritance of type I and type III von Willebrand's disease in Israel: linkage analysis, carrier detection and prenatal diagnosis using three intragenic restriction fragment length polymorphisms

N. Kornbrot, U. Seligsohn, A. Zivelin, 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Association of von Willebrand's disease with plasma cell dyscrasia and gastrointestinal angiodysplasia.

J. Papo, P. Rozen, U. Seligsohn, 1990, Israel journal of medical sciences.

Treatment of inherited platelet disorders

U. Seligsohn, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

A common ancestral mutation (C128X) occurring in 11 non‐Jewish families from the UK with factor XI deficiency

R. Mountford, P. Bolton-Maggs, S. Keeney, 2004, Journal of thrombosis and haemostasis : JTH.

A unique interaction between (cid:1) IIb and (cid:2) 3 in the head region is essential for outside-in signaling–related functions of (cid:1) IIb (cid:2) 3 integrin

M. Landau, N. Rosenberg, U. Seligsohn, 2010 .

A new mechanism for inherited factor XI deficiency

U. Seligsohn, 2004 .

ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families.

R. Kaufman, C. Négrier, D. Ginsburg, 1999, Blood.

Identification and Functional Analysis of Two Novel Mutations in the Multidrug Resistance Protein 2 Gene in Israeli Patients with Dubin-Johnson Syndrome*

S. Muallem, N. Rosenberg, U. Seligsohn, 2001, The Journal of Biological Chemistry.

Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction.

H. Hod, M. Modan, G. Barbash, 1989, The American journal of cardiology.

Natural and Artificial Mutations in αIIb Integrin Lead to a Structural Deformation of a Calcium-Binding Site

W. Mansour, Y. Einav, N. Rosenberg, 2014, The Protein Journal.

Golgi apparatus formation, but impair its transport from the endoplasmic reticulum to the patients with Glanzmann thrombasthenia enable GPIIb/IIIa complex Major mutations in calf-1 and calf-2 domains of glycoprotein IIb in

V. Sobolev, N. Rosenberg, H. Peretz, 2013 .

Molecular diversity of Glanzmann thrombasthenia in southern India: new insights into mRNA splicing and structure–function correlations of αIIbβ3 integrin (ITGA2B, ITGB3)

M. Landau, B. Coller, A. Srivastava, 2006, Human mutation.

Major mutations in calf-1 and calf-2 domains of glycoprotein IIb in patients with Glanzmann thrombasthenia enable GPIIb/IIIa complex formation, but impair its transport from the endoplasmic reticulum to the Golgi apparatus.

V. Sobolev, N. Rosenberg, H. Peretz, 2003, Blood.

The role of protein disulfide isomerase in the post-ligation phase of β3 integrin-dependent cell adhesion.

J. Lahav, R. Ram, N. Rosenberg, 2015, Thrombosis research.

Disulfide bond exchanges in integrins αIIbβ3 and αvβ3 are required for activation and post-ligation signaling during clot retraction.

J. Lahav, N. Rosenberg, U. Seligsohn, 2014, Thrombosis research.

The Role Of Protein Disulfide Isomerase In The Post-Ligation Phase Of β3 Integrin-Dependent Cell Adhesion

J. Lahav, R. Ram, N. Rosenberg, 2013 .

Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis.

H. Mandel, M. Berant, C. Jakobs, 1996, The New England journal of medicine.

Deciphering the mystery of combined factor V and factor VIII deficiency

D. Ginsburg, U. Seligsohn, David Ginsburg, 2006, Journal of thrombosis and haemostasis : JTH.

Combined factors V and VIII deficiency — the solution

R. Kaufman, C. Kessler, D. Ginsburg, 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

Mendelian diseases among Roman Jews: implications for the origins of disease alleles.

H. Ostrer, K. Nafa, L. Luzzatto, 1999, The Journal of clinical endocrinology and metabolism.

Cyclosporine Therapy for Acquired Factor VIII Inhibitor in a Patient with Systemic Lupus Erythematosus

S. Schulman, U. Martinowitz, D. Varon, 1996, Thrombosis and Haemostasis.

Rare bleeding disorders

P. Mannucci, F. Peyvandi, R. Palla, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemia.

H. Hod, Y. Mandel, G. Barbash, 1990, Journal of the American College of Cardiology.

High prevalences of vitamin B12 and folic acid deficiency in elderly subjects in Israel

A. Chetrit, B. Sela, O. Shpilberg, 2003, British journal of haematology.

Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy.

H. Halkin, G. Soff, U. Seligsohn, 1987, Thrombosis research.

The Relative Frequency of Hereditary Thrombotic Disorders Among 107 Patients with Thrombophilia in Israel

A. Zivelin, U. Seligsohn, A. Zivelin, 1989, Thrombosis and Haemostasis.

Hepatic computerized tomography in the Dubin-Johnson syndrome: increased liver density as a diagnostic aid.

M. Modan, U. Seligsohn, M. Shani, 1985, Computerized radiology : official journal of the Computerized Tomography Society.

Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.

J. Griffin, S. Rapaport, B. Osterud, 1979, The Journal of clinical investigation.

Effect of four missense mutations in the factor XIII A-subunit gene on protein stability: studies with recombinant proteins

R. Dardik, N. Rosenberg, U. Seligsohn, 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Factor XIII Deficiency due to a Leu660Pro Mutation in the Factor XIII Subunit-a Gene in Three Unrelated Palestinian Arab Families

V. Yee, B. Brenner, A. Inbal, 1997, Thrombosis and Haemostasis.

Reduced incidence of ischemic stroke in patients with severe factor XI deficiency.

D. Tanné, D. Steinberg, U. Seligsohn, 2008, Blood.

Cataract extraction without prophylactic treatment in patients with severe factor XI deficiency.

I. Fabian, J. Moisseiev, U. Seligsohn, 2009, American journal of ophthalmology.

Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb/IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis.

D. Harats, B. Coller, O. Shpilberg, 2002, Circulation.

Factor XI deficiency in Ashkenazi Jews in Israel.

E. Davie, R. Asakai, U. Seligsohn, 1991, The New England journal of medicine.

Glanzmann's thrombasthenia associated with deletion-insertion and alternative splicing in the glycoprotein IIb gene.

B. Coller, P. Newman, N. Rosenberg, 1995, Blood.

A mutation in the β3 cytoplasmic tail causes variant Glanzmann thrombasthenia by abrogating transition of αIIbβ3 to an active state

N. Rosenberg, U. Seligsohn, H. Hauschner, 2012, Journal of thrombosis and haemostasis : JTH.

Association between hyperflexibility of the thumb and an unexplained bleeding tendency: is it a rule of thumb?

G. Rechavi, G. Kenet, C. Kaplinsky, 1998, British journal of haematology.

Thrombophilic factors are not the leading cause of thrombosis in Behçet’s disease

M. Ehrenfeld, J. Griffin, D. Harats, 2004, Annals of the rheumatic diseases.

C-deficient newborn with massive thrombosis large family of a previously described homozygous protein R506Q mutation of factor V and for T298M mutation of protein C in a Venous thromboembolism associated with double heterozygosity for

J. Griffin, B. Brenner, U. Seligsohn, 2011 .

Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis

J. Griffin, B. Brenner, U. Seligsohn, 1996 .

J. Griffin, B. Brenner, U. Seligsohn, 1996, Blood.

Prenatal diagnosis of hereditary protein C deficiency.

K. Nicolaides, C. Rodeck, D. Millar, 1985, The New England journal of medicine.

A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene.

C. Mannhalter, M. Horellou, A. Zivelin, 1998, Blood.

Evidence for the participation of both activated factor XII and activated factor IX in cold-promoted activation of factor VII.

J. Griffin, B. Osterud, U. Seligsohn, 1978, Thrombosis research.

Abnormal cytoplasmic extensions associated with active &agr;IIb&bgr;3 are probably the cause for macrothrombocytopenia in Glanzmann thrombasthenia-like syndrome

A. Savoia, W. Mansour, N. Rosenberg, 2015, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Abnormal cytoplasmic extensions associated with active &agr;IIb&bgr;3 are probably the cause for macrothrombocytopenia in Glanzmann thrombasthenia-like syndrome

A. Savoia, W. Mansour, N. Rosenberg, 2015, Blood Coagulation and Fibrinolysis.

Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis

U. Seligsohn, B. Coller, P. Little, 1987 .

Hereditary deficiency of all vitamin K‐dependent procoagulants and anticoagulants

B. Brenner, B. Brenner, C. Keller, 1990, British journal of haematology.

Combined Factor V and Factor VIII Deficiency among Non-Ashkenazi Jews

A. Zivelin, U. Seligsohn, E. Zwang, 1982 .

Coupled amidolytic assay for factor VII: its use with a clotting assay to determine the activity state of factor VII.

B. Osterud, U. Seligsohn, S. Rapaport, 1978, Blood.

Von Willebrand Factor Multimer Patterns in Pregnancy-Induced Hypertension

B. Brenner, U. Seligsohn, E. Zwang, 1989, Thrombosis and Haemostasis.

Possible role of factor XIII subunit A in Fcgamma and complement receptor-mediated phagocytosis.

R. Ádány, S. Lopaciuk, U. Seligsohn, 2004, Cellular immunology.

The effect of leukocytic extract on fibrinogen synthesis in rabbits.

U. Seligsohn, B. Klein, 1975, Thrombosis research.

ETRO Working Party on Factor XIII Questionnaire on Congenital Factor XIII Deficiency in Europe: Status and Perspectives

F. Rodeghiero, R. Seitz, S. Lopaciuk, 1996, Seminars in thrombosis and hemostasis.

Glanzmann thrombasthenia: new insights from an historical perspective.

B. Coller, P. Newman, H. Peretz, 1994, Seminars in hematology.

ADAMTS-13 regulates platelet adhesion under flow

N. Savion, B. Shenkman, D. Varon, 2006, Thrombosis and Haemostasis.

anemia gene FAC in the Ashkenazi Jewish population Carrier frequency of the IVS4 + 4 A-->T mutation of the Fanconi

A. Auerbach, U. Seligsohn, P. Verlander, 2011 .

alternative splicing in the glycoprotein IIb gene Glanzmann's thrombasthenia associated with deletion-insertion and

B. Coller, P. Newman, N. Rosenberg, 2011 .

Possible Role of Fibrinogen in the Aggregation of White Blood Cells

S. Berliner, U. Seligsohn, J. Agmon, 1987, Thrombosis and Haemostasis.

Structural integrity of the glycoprotein IIb and IIIa genes in Glanzmann thrombasthenia patients from Israel.

T. Quertermous, B. Coller, P. Skoglund, 1988, Blood.

Immunological Studies in Combined Factor V and Factor VIII Deficiency

A. Bloom, J. Giddings, U. Seligsohn, 1977, British journal of haematology.

Clinical utility gene card for: Glanzmann thrombasthenia

P. Nurden, A. Nurden, U. Seligsohn, 2012, European Journal of Human Genetics.

Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy

D. Steinberg, U. Seligsohn, O. Salomon, 1999, Eye.

Genetic susceptibility to venous thrombosis.

U. Seligsohn, A. Lubetsky, 2001, The New England journal of medicine.

Thrombophilia as a Multigenic Disorder

A. Zivelin, U. Seligsohn, A. Zivelin, 1997, Thrombosis and Haemostasis.

Hereditary factor XIII deficiency: report of four families and definition of the carrier state

M. Modan, A. Lusky, A. Zivelin, 1984, British journal of haematology.

patients with inherited factor XI deficiency Prevalence, causes, and characterization of factor XI inhibitors in

M. Steinberg, Christine A. Lee, R. Loewenthal, 2013 .

The human platelet alphaIIb gene is not closely linked to its integrin partner beta3.

M. Poncz, M. A. Thornton, M. Korostishevsky, 1999, Blood.

Title Page / Table of Contents / Preface

F. Sofi, R. Abbate, P. Morange, 2003, Pathophysiology of Haemostasis and Thrombosis.

Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking [see comments]

B. Coller, S. M. West, U. Seligsohn, 1991 .

Ilio-psoas hematoma—its detection, and treatment with special reference to hemophilia

H. Horoszowski, U. Martinowitz, U. Seligsohn, 2004, Archives of orthopaedic and traumatic surgery.

Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion.

B. Osterud, C. Kasper, U. Seligsohn, 1979, Blood.

Haemophiliac Hands—A Three Year Follow-Up Study

H. Horoszowski, U. Martinowitz, U. Seligsohn, 1982, The Hand.

Current strategy for genetic analysis of haemophilia A families

U. Martinowitz, R. Dardik, H. Peretz, 1996, Haemophilia : the official journal of the World Federation of Hemophilia.

Combined Factor‐V and Factor‐ VIII Deficiency: Report of Four Cases

B. Ramot, U. Seligsohn, 1969, British journal of haematology.

A mutation in LMAN1 (ERGIC-53) causing combined factor V and factor VIII deficiency is prevalent in Jews originating from the island of Djerba in Tunisia

D. Ginsburg, O. Shpilberg, N. Rosenberg, 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex

R. Kaufman, D. Ginsburg, S. Pipe, 2003, Nature Genetics.

Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene.

F. Bauduer, L. Ducout, N. Rosenberg, 2002, Blood.

Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein &agr;IIb&bgr;3 (GPIIb/IIIa) and &agr;v&bgr;3 Receptors Are Not Protected From Atherosclerosis

D. Harats, B. Coller, O. Shpilberg, 2002 .

New observations on factor XI deficiency

U. Seligsohn, O. Salomon, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Identification of a region in glycoprotein IIIa involved in subunit association with glycoprotein IIb: further lessons from Iraqi-Jewish Glanzmann thrombasthenia.

L. Trakhtenbrot, R. Dardik, N. Rosenberg, 2001, Blood.

Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency

D. Steinberg, U. Seligsohn, A. Zivelin, 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Bleeding predictors in factor‐XI‐deficient patients

A. Laor, B. Brenner, A. Zivelin, 1997, Blood Coagulation and Fibrinolysis.

Factor XI Deficiency

U. Seligsohn, Uri Seligsohn, 1993, Thrombosis and Haemostasis.

Factor XI deficiency: detection and management during urological surgery.

U. Seligsohn, P. Jonas, A. Sidi, 1978, The Journal of urology.

Inherited platelet disorders

A. Nurden, K. Freson, U Seligsohn, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Extra-adrenal effect of ACTH on fibrinogen synthesis.

U. Seligsohn, S. Rapaport, P. Kuefler, 1973, The American journal of physiology.

Inherited Thrombophilia: Part 1

P. Mannucci, F. Rosendaal, J. Miletich, 1996, Thrombosis and Haemostasis.

Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients

M. Landau, H. Tamary, N. Rosenberg, 2004, Journal of thrombosis and haemostasis : JTH.

the circulation after infusion Activated factor VII: presence in factor IX concentrates and persistence in

C. Kasper, U. Seligsohn, B. Østerud, 2011 .

A Laser Scalpel for Operations on Hemophiliacs

H. Horoszowski, U. Seligsohn, M. Heim, 1977 .

A Method for Assessment and Grading of Osteoarthropathy in Hemophiliacs

H. Horoszowski, U. Seligsohn, M. Heim, 1977 .

The laboratory diagnosis of haemophilia: Recommendations by the Laboratory Activities Committee of the World Federation of Hemophilia

S. Kitchen, I. Peake, U. Seligsohn, 1995, Haemophilia : the official journal of the World Federation of Hemophilia.

Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma

U. Martinowitz, A. Zivelin, U. Seligsohn, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Factor XI deficiency in humans

U. Seligsohn, 2009, Journal of thrombosis and haemostasis : JTH.

A proposed system of classification of hemophilia centers for the World Federation of Hemophilia (W.F.H.).

P. Levine, H. Brackmann, U. Seligsohn, 2009, Scandinavian journal of haematology. Supplementum.

High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews.

U. Seligsohn, Uri Seligsohn, 1978, Blood.

Hemophilia and other clotting disorders.

U. Seligsohn, 1973, Israel journal of medical sciences.

Glanzmann thrombasthenia: a model disease which paved the way to powerful therapeutic agents

U. Seligsohn, 2002, Pathophysiology of Haemostasis and Thrombosis.

PRENATAL DIAGNOSIS OF GLANZMANN'S THROMBASTHENIA

K. Nicolaides, C. Rodeck, B. Coller, 1985, The Lancet.

A Glanzmann’s Thrombasthenia Cluster Among Iraqi Jews in Israel

U. Seligsohn, S. Rososhansky, 1984, Thrombosis and Haemostasis.

Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the Iraqi‐Jewish and Arab populations of Israel: comparison of techniques for carrier detection

B. Coller, M. Modan, A. Lusky, 1986, British journal of haematology.

Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus.

Z. Hochberg, B. Brenner, U. Seligsohn, 1988, The Journal of clinical endocrinology and metabolism.

Rapid Publication Linkage of Combined Factors V and VIII Deficiency to Chromosome 18 q by Homozygosity Mapping

N. D. Arnold, R. Kaufman, D. Ginsburg, 2013 .

Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mapping.

N. D. Arnold, R. Kaufman, D. Ginsburg, 1997, The Journal of clinical investigation.

Inhibitors to Factor XI in patients with severe Factor XI deficiency.

U. Seligsohn, A. Zivelin, O. Salomon, 2006, Seminars in hematology.

Inherited factor XI deficiency confers no protection against acute myocardial infarction

D. Steinberg, D. Steinberg, B. Ravid, 2003, Journal of thrombosis and haemostasis : JTH.

The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin.

M. Mittelman, O. Shpilberg, B. Brenner, 1997, Blood.

Seven novel mutations in the factor XIII A‐subunit gene causing hereditary factor XIII deficiency in 10 unrelated families

M. Landau, R. Saxena, N. Rosenberg, 2004, Journal of thrombosis and haemostasis : JTH.

Trp207Gly in platelet glycoprotein Ibα is a novel mutation that disrupts the connection between the leucine‐rich repeat domain and the disulfide loop structure and causes Bernard–Soulier syndrome

M. Landau, S. Izraeli, S. Lalezari, 2007, Journal of thrombosis and haemostasis : JTH.

One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews.

A. Chetrit, O. Shpilberg, A. Zivelin, 1995, Blood.

factor VIII Genotype-phenotype correlation in combined deficiency of factor V and

P. Platzer, R. Kaufman, J. Mahlangu, 2011 .

Mutations in the ER–Golgi Intermediate Compartment Protein ERGIC-53 Cause Combined Deficiency of Coagulation Factors V and VIII

H. Hauri, R. Kaufman, D. Ginsburg, 1998, Cell.

Combined Factor V and Factor VIII Deficiency among Non‐Ashkenazi Jews

A. Zivelin, U. Seligsohn, E. Zwang, 1983, The New England journal of medicine.

Molecular characterization of four novel mutations causing factor VII deficiency.

H. Tamary, R. Zaizov, B. Brenner, 2000, The hematology journal : the official journal of the European Haematology Association.

Factor XI in haemostasis and thrombosis: Past, present and future

U. Seligsohn, Uri Seligsohn, 2007, Thrombosis and Haemostasis.

Characterization of Three Mutations Causing von Willebrand Disease Type IIA in Five Unrelated Families

Pille Harrison, I. Rabinowitz, B. Brenner, 1992, Thrombosis and Haemostasis.

Clinical bleeding due to diclofenac (Voltaren)

R. Michalevicz, U. Seligsohn, 1982, Arthritis and rheumatism.

Abnormal excretion of the isomers of urinary coproporphyrin by patients with Dubin-Johnson syndrome in Israel.

C. Rimington, U. Seligsohn, M. Shani, 1971, Clinical science.

Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases.

U. Seligsohn, M. Shani, C. Sheba, 1970, The Quarterly journal of medicine.

Clinical and Laboratory Aspects of Disseminated Intravascular Coagulation (DIC): A Study of 118 Cases

M. Modan, T. Siegal, U. Seligsohn, 1978, Thrombosis and Haemostasis.

Simultaneous genotyping of coagulation factor XI type II and type III mutations by multiplex real-time polymerase chain reaction to determine their prevalence in healthy and factor XI-deficient Italians

P. Mannucci, S. Duga, G. Castaman, 2008, Haematologica.

Age estimates of ancestral mutations causing factor VII deficiency and Dubin–Johnson syndrome in Iranian and Moroccan Jews are consistent with ancient Jewish migrations

N. Rosenberg, U. Seligsohn, A. Zivelin, 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Effect of phenobarbital on liver functions in patients with Dubin-Johnson syndrome.

U. Seligsohn, M. Shani, J. Ben-Ezzer, 1974, Gastroenterology.

Risk Factors Associated with Postpartum Ovarian Vein Thrombosis

Y. Itzchak, J. Bar-ziv, D. Shaham, 1999, Thrombosis and Haemostasis.

Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.

D. Steinberg, S. Berliner, U. Martinowitz, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C.

José A Fernández, H. Halkin, J. Griffin, 1999, Blood.

Lysine binding to activated human platelets and its similarity to fibrinogen binding.

G. Agam, U. Seligsohn, R. Luria, 1985, Biochimica et biophysica acta.

Factor VII in plasma of women taking oral contraceptives. Lack of cold activation under blood bank conditions

A. Zivelin, U. Seligsohn, E. Zwang, 1984, Transfusion.

Cold-promoted activation of factor VII: is It a problem under blood bank conditions?

A. Zivelin, U. Seligsohn, S. Bar-Shani, 1983, Haemostasis.

Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis

D. Steinberg, D. Varon, U. Seligsohn, 2010, Thrombosis and Haemostasis.

Delayed Incorporation of [75Se]Selenomethionine into Fibrinogen: Its Effect upon Kinetic Studies of Fibrinogen with [75Se]Selenomethionine in Rabbits

U. Seligsohn, H. Rostami, S. Rapaport, 1974, British journal of haematology.

The effect of the plasma levels of proteins C and S on the prediction of warfarin maintenance dose requirements

H. Halkin, U. Seligsohn, A. Lubetsky, 1992, Clinical pharmacology and therapeutics.

Disseminated Intravascular Coagulation in Experimental Heatstroke

Y. Shapiro, B. Ramot, U. Seligsohn, 1971, Thrombosis and Haemostasis.

Homozygous protein C deficiency

U. Seligsohn, 1986 .

The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans.

Y. Ikeda, E. Geffen, M. Murata, 2002, American journal of human genetics.

Failure to detect variant (CRM+) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: a study of 125 patients of several ethnic backgrounds.

O. Ratnoff, H. Saito, U. Seligsohn, 1985, The Journal of laboratory and clinical medicine.

Severe Hereditary Deficiency of Factor VII during Pregnancy

B. Ramot, U. Seligsohn, M. Shani, 1970, Thrombosis and Haemostasis.

determine the activity state of factor VII Coupled amidolytic assay for factor VII: its use with a clotting assay to

B. Osterud, U. Seligsohn, S. Rapaport, 2011 .

Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.

B. Coller, U. Seligsohn, E. Peerschke, 1986, The Journal of laboratory and clinical medicine.

Persistent neonatal thrombocytopenia can be caused by IgA antiplatelet antibodies in breast milk of immune thrombocytopenic mothers.

N. Rosenberg, U. Seligsohn, H. Hauschner, 2015, Blood.

Definition of the population at risk of bleeding due to factor XI deficiency in Ashkenazic Jews and the value of activated partial thromboplastin time in its detection.

M. Modan, U. Seligsohn, 1981, Israel journal of medical sciences.

Point mutations regarded as missense mutations cause splicing defects in the factor XI gene

F. Bauduer, A. Zivelin, N. Rosenberg, 2011, Journal of thrombosis and haemostasis : JTH.

Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune‐mediated clearance of von Willebrand factor

B. Shenkman, D. Varon, R. Dardik, 1997, British journal of haematology.

Prevention program of type I Glanzmann thrombasthenia in Israel: prenatal diagnosis.

K. Nicolaides, C. Rodeck, B. Coller, 1988, Current studies in hematology and blood transfusion.

Unusual course of infectious mononucleosis.

J. Zahavi, U. Seligsohn, 1967, JAMA.

[International postgraduate training program in medicine: survey of 13 training courses, 1988-1994].

U. Seligsohn, R. Maymon, M. Fainaru, 1995, Harefuah.

A novel ancestral splicing mutation in the multidrug resistance protein 2 gene causes Dubin-Johnson syndrome in Ashkenazi Jewish patients.

I. Goldberg, N. Rosenberg, U. Seligsohn, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Dubin-Johnson syndrome in Israel. II. Association with factor-VII deficiency.

B. Ramot, U. Seligsohn, M. Shani, 1970, The Quarterly journal of medicine.

An allosteric disulfide bond is involved in enhanced activation of factor XI by protein disulfide isomerase

A. Yeheskel, U. Seligsohn, R. Mor-cohen, 2016, Journal of thrombosis and haemostasis : JTH.

A single genetic origin for a common Caucasian risk factor for venous thrombosis.

J. Griffin, I. Pabinger, A. Eldor, 1997, Blood.

Effects of ADP and ATP on Bovine Fibrinogen‐ and Ristocetin‐Induced Platelet Aggregation in Glanzmann's Thrombasthenia

U. Seligsohn, I. Cohen, T. Glaser, 1975, British journal of haematology.

Clinical and Genetic Aspects of Glanzmann’s Thrombasthenia in Israel

B. Ramot, U. Seligsohn, N. Reichert, 1975, Thrombosis and Haemostasis.

Platelet glycoprotein IIb/IIIa receptors and Glanzmann's thrombasthenia.

D. French, U. Seligsohn, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Dental surgery in patients with severe factor XI deficiency without plasma replacement.

B. Brenner, S. Berliner, I. Horowitz, 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Prenatal diagnosis of Glanzmann thrombasthenia using the polymorphic markers BRCA1 and THRA1 on chromosome 17

R. Berkowitz, C. Eng, D. French, 1998, British journal of haematology.

Glanzmann thrombasthenia caused by an 11.2-kb deletion in the glycoprotein IIIa (beta3) is a second mutation in Iraqi Jews that stemmed from a distinct founder.

R. Dardik, N. Rosenberg, H. Peretz, 1997, Blood.

Cerebrovascular Events in Patients With Significant Stenosis of the Carotid Artery Are Associated With Hyperhomocysteinemia and Platelet Antigen-1 (Leu33Pro) Polymorphism

A. Chetrit, B. Sela, B. Ravid, 2001, Stroke.

Platelets from Calreticulin mutated essential thrombocythemia patients are less reactive than JAK2 V617F mutated platelets

N. Rosenberg, U. Seligsohn, H. Hauschner, 2019, American journal of hematology.

Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males.

B. Modan, D. Freimark, A. Chetrit, 1999, Blood.

The prevalence of factor V G1691A but not of prothrombin G20210A and methylenetetrahydrofolate reductase C677T is remarkably low in French Basques

F. Bauduer, L. Ducout, A. Zivelin, 2004, Journal of thrombosis and haemostasis : JTH.

Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source

D. Steinberg, B. Sela, J. Moisseiev, 2001, Eye.

Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy.

D. Steinberg, D. Steinberg, B. Ravid, 1999, Ophthalmology.

Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients

B. Coller, M. Chandy, S. Nair, 2006, Journal of thrombosis and haemostasis : JTH.

Detection of the Glanzmann's Thrombasthenia Mutations in Arab and Iraqi-Jewish Patients by Polymerase Chain Reaction and Restriction Analysis of Blood or Urine Samples

B. Coller, P. Newman, H. Peretz, 1991, Thrombosis and Haemostasis.

Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago.

R. Bertina, P. Kyrle, J. Emmerich, 2006, Blood.

An αIIb mutation in patients with Glanzmann thrombasthenia located in the N‐terminus of blade 1 of the β‐propeller (Asn2Asp) disrupts a calcium binding site in blade 6

W. Mansour, Y. Einav, N. Rosenberg, 2011, Journal of thrombosis and haemostasis : JTH.

Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3.

M. Landau, B. Coller, N. Rosenberg, 2007, Thrombosis and haemostasis.

A novel Phe171Cys mutation in integrin αIIb causes Glanzmann thrombasthenia by abrogating αIIbβ3 complex formation

M. Landau, G. Rechavi, J. Luboshitz, 2004, Journal of thrombosis and haemostasis : JTH.

Glanzmann thrombasthenia in two Iraqi-Jewish siblings is caused by a novel splice junction mutation in the glycoprotein IIb.

B. Brenner, R. Dardik, N. Rosenberg, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Ala244Val Is a Common, Probably Ancient Mutation Causing Factor VII Deficiency in Moroccan and Iranian Jews

O. Dym, A. Luder, H. Tamary, 1996, Thrombosis and Haemostasis.

Detection of Haemophilia A Carriers by Replicate Factor VIII Activity and Factor VIII Antigenicity Determinations

M. Modan, A. Zivelin, U. Seligsohn, 1979, British journal of haematology.

[Massive bleeding due to primary fibrinolysis following rhinoplasty].

U. Seligsohn, A. Man, 1972, Harefuah.

[Inherited bleeding disorders common in Jews].

U. Seligsohn, 2010, Harefuah.

The neurology of cobalamin deficiency in an elderly population in Israel

N. Gadoth, A. Chetrit, B. Sela, 2005, Journal of Neurology.

Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI–Glu555): a cross‐reactive material positive variant defective in factor IX activation

M. Landau, S. Bulvik, A Zivelin, 2004, Journal of thrombosis and haemostasis : JTH.

Three residues at the interface of factor XI (FXI) monomers augment covalent dimerization of FXI

M. Landau, N. Rosenberg, U. Seligsohn, 2009, Journal of thrombosis and haemostasis : JTH.

ancestral Cys38Arg mutation in the factor XI gene Factor XI deficiency in French Basques is caused predominantly by an

F. Bauduer, L. Ducout, N. Rosenberg, 2013 .

The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction.

D. Steinberg, E. Schiff, Y. Zalel, 2004, American journal of obstetrics and gynecology.

Plasma levels of microparticles at 24 weeks of gestation do not predict subsequent pregnancy complications.

D. Steinberg, R. Achiron, R. Dardik, 2009, Fertility and sterility.

High prevalence and impact of subnormal serum vitamin B12 levels in Israeli elders admitted to a geriatric hospital.

D. Shahar, U. Seligsohn, A. Shahar, 2001, The journal of nutrition, health & aging.

Platelet factor XI: intracellular localization and mRNA splicing following platelet activation.

N. Rosenberg, U. Seligsohn, H. Hauschner, 2017, Blood cells, molecules & diseases.

Specific Cysteines in β3 Are Involved in Disulfide Bond Exchange-dependent and -independent Activation of αIIbβ3*

M. Landau, J. Lahav, N. Rosenberg, 2008, Journal of Biological Chemistry.

Unique Disulfide Bonds in Epidermal Growth Factor (EGF) Domains of β3 Affect Structure and Function of αIIbβ3 and αvβ3 Integrins in Different Manner

M. Landau, W. Mansour, Y. Einav, 2012, The Journal of Biological Chemistry.

Risk factors for failure of heparin thromboprophylaxis in patients with acute traumatic spinal cord injury.

G. Zeilig, A. Lubetsky, I. Asher, 2010, Thrombosis research.

The Dubin Johnson syndrome and pregnancy.

U. Seligsohn, M. Shani, 1977, Acta hepato-gastroenterologica.

Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolism.

D. Steinberg, R. Dardik, N. Rosenberg, 2001, The hematology journal : the official journal of the European Haematology Association.

Gilbert syndrome and factor-VII deficiency.

B. Ramot, U. Seligsohn, M. Shani, 1970, Lancet.

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Extensive Venous and Arterial Thrombosis Associated With an Inhibitor to Activated Protein C

H. Halkin, J. Griffin, U. Martinowitz, 2016 .

Coexistence of factor XI (plasma thromboplastin antecedent) deficiency and Gaucher's disease.

U. Seligsohn, A. Many, C. Klibansky, 1976, Israel journal of medical sciences.

Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis.

B. Coller, U. Seligsohn, P. Little, 1987, Blood.

Disulfide bond disruption by a β3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active αIIbβ3

M. Landau, B. Coller, N. Rosenberg, 2007, Thrombosis and Haemostasis.

58. Factor XI Deficiency

U. Seligsohn, P. Bolton-Maggs, 2014 .

A 14‐bp deletion (codon 554 del AAGgtaacagagtg) at exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency

H. Peretz, U. Seligsohn, A. Zivelin, 1996, Human mutation.

Of four mutations in the factor VII gene in Tunisian patients, one novel mutation (Ser339Phe) in three unrelated families abrogates factor X activation

M. Landau, J. Rosa, N. Rosenberg, 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

DUBIN-JOHNSON SYNDROME IN ISRAEL

B. Ramot, U. Seligsohn, M. Shani, 1970 .

CYCLES OF REOCCLUSION-REPERFUSION DURING RT-PA TREATMENT IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (AMI)

H. Hod, G. Barbash, U. Seligsohn, 1987, Thrombosis and Haemostasis.

Immunoblot analysis of platelet glyeoprotein IIb in patients with Glanzmann thrombasthenia in Israel

B. Coller, M. Ginsberg, E. Plow, 1989, British journal of haematology.

The reduced form of coagulation factor XI is associated with illness severity and coagulopathy in critically-ill septic patients

Samuel M. Brown, Robert A. Campbell, M. Rondina, 2019, Journal of Thrombosis and Thrombolysis.

Dubin-Johnson Syndrome. Abnormal excretion of the isomers of urinary coproporphyrin by clinically unaffected family members.

U. Seligsohn, M. Shani, A. Szeinberg, 1973, Israel journal of medical sciences.

Inherited Thrombophilia: Part 1

P. Mannucci, F. Rosendaal, J. Miletich, 1996, Thrombosis and Haemostasis.

58. Factor XI Deficiency

U. Seligsohn, P. Bolton-Maggs, 2014 .

Quantitation by flow cytometry of anthracycline drug uptake by peripheral blood and bone marrow cells in human leukemias.

R. Michalevicz, U. Seligsohn, E. Sahar, 1986, Experimental hematology.

Multiple myeloma with terminal erythroleukemia.

B. Ramot, U. Seligsohn, D. Meytes, 1976, Acta Haematologica.

Induction of an inhibitor antibody to factor XI in a patient with severe inherited factor XI deficiency by Rh immune globulin.

J. Teitel, U. Seligsohn, A. Zivelin, 2008, Blood.

Responses of Platelets to Strains of Streptococcus sanguis: Findings in Healthy Subjects, Bernard-Soulier, Glanzmann’s, and Collagen-Unresponsive Patients

J. Sixma, M. Herzberg, H. Nieuwenhuis, 1987, Thrombosis and Haemostasis.

Reduced incidence of ischemic stroke in patients with severe factor XI deficiency.

D. Tanné, D. Steinberg, U. Seligsohn, 2008, Blood.

Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction.

H. Hod, E. Kaplinsky, A. Battler, 1990, The American journal of cardiology.

Factor XI deficiency in humans

U. Seligsohn, 2009, Journal of thrombosis and haemostasis : JTH.

Unique Disulfide Bonds in Epidermal Growth Factor (EGF) Domains of β3 Affect Structure and Function of αIIbβ3 and αvβ3 Integrins in Different Manner

M. Landau, W. Mansour, Y. Einav, 2012, The Journal of Biological Chemistry.

Chronic monocytic leukemia: a case with an eight-year survival.

B. Ramot, U. Seligsohn, 1967, Israel journal of medical sciences.

False‐positive tests for heparin‐induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus

A. Greinacher, R. Pauzner, B. Shenkman, 2009, Journal of thrombosis and haemostasis : JTH.

Angio-immunoblastic lymphadenopathy: a case with a 17-year follow-up

R. Michalevicz, U. Seligsohn, A. Behar, 1982, Postgraduate medical journal.

Characterization of seven novel mutations causing factor XI deficiency

M. Landau, F. Bauduer, G. Kenet, 2007, Haematologica.

patients with inherited factor XI deficiency Prevalence, causes, and characterization of factor XI inhibitors in

Christine A. Lee, R. Loewenthal, N. O'Connell, 2013 .

The activated partial thromboplastin time and factor XI deficiency.

U. Seligsohn, 1986, Annals of internal medicine.